The development saga for the depression molecule has been rocky for years, unable to ease symptoms in multiple late-stage trials.

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

The acquisition of Avivia aligns with Ofichem’s broader merger and acquisition agenda and ongoing investment strategy.

Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...

Documented, an immigrant-facing nonprofit newsroom, shares the creative and innovative ways they've gone about reaching underserved communities.

Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm ...

In today’s tech-dominant environment, high-performance engineering teams are crucial to building the next generation sol ...

SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its ...

Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years ...